Market Overview The trifluridine tipiracil tablet market is experiencing growth as this combination chemotherapy demonstrates efficacy in advanced colorectal cancer and gastric cancer. The global market is projected to exceed USD 2.8 billion through 2030, driven by cancer prevalence, treatment-resistant disease management, and clinical trial expansion. Trifluridine tipiracil treats cancer...